Isolation, Structure Elucidation, and Synthesis of Irlbacholine, 1,22-Bis[[[2-(trimethylammonium)ethoxy]phosphinyl]oxy]docosane: A Novel Antifungal Plant Metabolite from Irlbachia alata and Anthocleista djalonensis
Isolation, Structure Elucidation, and Synthesis of Irlbacholine, 1,22-Bis[[[2-(trimethylammonium)ethoxy]phosphinyl]oxy]docosane: A Novel Antifungal Plant Metabolite from Irlbachia alata and Anthocleista djalonensis
Process for the preparation of mono- and bis(phosphocholine)
申请人:Shaman Pharmaceuticals, Inc.
公开号:US05811568A1
公开(公告)日:1998-09-22
This invention pertains to a synthetic process for obtaining a unique phosphocholine derivative which has been isolated from the leaves of the plant Irbachia alata, identified to be 1,22-bis\x9b2-(trimethylammonium)ethylphosphatyl! docosane is disclosed. Also disclosed is a synthetic process for obtaining a novel class of mono- and bis(phosphocholine) derivatives which are useful as antiinfective agents. The compounds are particularly effective in treating fungal infections, especially those caused by Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus.
Isolation, Structure Elucidation, and Synthesis of Irlbacholine, 1,22-Bis[[[2-(trimethylammonium)ethoxy]phosphinyl]oxy]docosane: A Novel Antifungal Plant Metabolite from Irlbachia alata and Anthocleista djalonensis
作者:Donald E. Bierer、R. Eric Gerber、Shivanand D. Jolad、Rosa P. Ubillas、Joaquin Randle、Ewa Nauka、John Latour、Jeffrey M. Dener、Diana M. Fort